metoclopramide has been researched along with batanopride in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 10 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, MA; Brown, M; Crenshaw, RR; Fuller, CE; Juby, PF; Luke, GM; Matiskella, JA; Monković, I; Montzka, TA; Willner, D | 1 |
| Agharkar, SN; House, CA; Nassar, MN | 1 |
| Findlay, B; Kaizer, L; Laberge, F; Latreille, J; Lofters, WS; Osoba, D; Pater, J; Rusthoven, J; Warr, D; Wilson, K | 1 |
| Gandara, DR; Hesketh, PJ | 1 |
| Fleming, GF; Francher, D; Janisch, L; McEvilly, JM; Smaldone, L; Vokes, EE | 1 |
| Dombernowsky, P; Herrstedt, J; Jeppesen, BH | 1 |
| King, GL | 1 |
| Aapro, M; Alberts, D; Brady, M; Comerski, C; Dorn, M; Fairchild, C; Plezia, P; Sartiano, G; Schwartz, SE; Smaldone, L | 1 |
| King, GL; Landauer, MR | 1 |
| Buyniski, JP; Crenshaw, RR; Gylys, JA; Nicolosi, WD; Wright, RN | 1 |
| Osoba, D; Pater, J; Rusthoven, J; Slamet, L; Warr, D; Zee, B | 1 |
| Brady, ME; Dandekar, KA; Foote, EF; Halstenson, CE; Keane, WF; Pykkonen, JL; Smaldone, L; St Peter, JV | 1 |
2 review(s) available for metoclopramide and batanopride
| Article | Year |
|---|---|
Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis.
Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dogs; Dopamine Antagonists; Female; Ferrets; Hemodynamics; Humans; Male; Metoclopramide; Mice; Middle Aged; Neoplasms; Rats; Serotonin Antagonists; Vomiting | 1990 |
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1994 |
4 trial(s) available for metoclopramide and batanopride
| Article | Year |
|---|---|
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart; Humans; Hypotension; Life Tables; Male; Methylprednisolone; Metoclopramide; Multivariate Analysis; Serotonin Antagonists; Treatment Outcome; Vomiting | 1991 |
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis.
Topics: Antiemetics; Cisplatin; Double-Blind Method; Drug Tolerance; Humans; Infusions, Intravenous; Metoclopramide; Time Factors; Vomiting | 1991 |
Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801).
Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Hypotension; Male; Metoclopramide; Middle Aged | 1991 |
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1994 |
7 other study(ies) available for metoclopramide and batanopride
| Article | Year |
|---|---|
Substituted benzamides. 1. Potential nondopaminergic antagonists of chemotherapy-induced nausea and emesis.
Topics: Animals; Antiemetics; Benzamides; Catalepsy; Chemical Phenomena; Chemistry; Cisplatin; Dogs; Dopamine Antagonists; Ferrets; Metoclopramide; Nausea; Rats; Structure-Activity Relationship | 1988 |
Stability of batanopride hydrochloride in aqueous solutions.
Topics: Antiemetics; Buffers; Hydrogen-Ion Concentration; Kinetics; Metoclopramide; Osmolar Concentration; Solutions; Water | 1992 |
Serotonin antagonists: a new class of antiemetic agents.
Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Metoclopramide; Ondansetron; Quinolizines; Receptors, Serotonin; Serotonin Antagonists; Tropanes; Tropisetron; Vomiting | 1991 |
Emesis and defecations induced by the 5-hydroxytryptamine (5-HT3) receptor antagonist zacopride in the ferret.
Topics: Administration, Oral; Animals; Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Defecation; Dose-Response Relationship, Drug; Ferrets; Granisetron; Indazoles; Injections, Intravenous; Male; Metoclopramide; Pyrazoles; Serotonin; Serotonin Antagonists; Vagotomy; Vomiting | 1990 |
Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.
Topics: Animals; Antiemetics; Behavior, Animal; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Dose-Response Relationship, Radiation; Ferrets; Gait; Injections, Intraperitoneal; Male; Metoclopramide; Radiation Injuries, Experimental; Vagotomy; Vomiting | 1990 |
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Cyclophosphamide; Dogs; Doxorubicin; Female; Ferrets; Male; Metoclopramide; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Reflex; Vomiting | 1988 |
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment.
Topics: Adult; Aged; Blood Proteins; Female; Humans; Kidney Diseases; Male; Metoclopramide; Middle Aged; Protein Binding; Serotonin Antagonists | 1993 |